Federica Cavallo

36PUBLICATIONS
122CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMolecular targetsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Oct 16, 2026
The Osteosarcoma Tumor Microenvironment: Supportive of Tumor Progression, Hostile to Immunity, but Therapeutically Targetable.

|Jul 28, 2026
Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer.

|Apr 14, 2026
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody.

Ahmad Salameh, Elisabetta Bolli, Manuela Iezzi

|Dec 11, 2025
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer.

Lidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo

|Jun 13, 2025
Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate Syndrome-Linked p63 Mutations Disrupt Keratinocyte Proliferation and Survival Through Oxidative Stress and Impaired Slc7a11 Expression.

Daniela Di Girolamo, Sara Palumbo, Dario Antonini

|Mar 10, 2025
Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols.

Mariateresa Camerino, Davide Giacobino, Lidia Tarone

Pageof 6

Frequent Collaborators

18 joint publications

Laura Conti

13 joint publications

Federica Riccardo

7 joint publications

Federica Cavallo

7 joint publications

Antonino Di Lorenzo